Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials. [electronic resource]
Producer: 20180703Description: 1279-1286 p. digitalISSN:- 1433-2965
- Adult
- Age Factors
- Aged
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Clinical Trials, Phase III as Topic
- Double-Blind Method
- Female
- Humans
- Lumbar Vertebrae -- physiopathology
- Male
- Middle Aged
- Osteoporosis -- blood
- Osteoporotic Fractures -- etiology
- Randomized Controlled Trials as Topic
- Risedronic Acid -- therapeutic use
- Spinal Fractures -- etiology
- Vitamin D -- analogs & derivatives
- Vitamin D Deficiency -- blood
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.